Byam Rebecca's Form 4 filing
HCW Biologics Inc. (HCWB) · filed Jun 15, 2022
- Accession no.
- 0001209191-22-037110
- Filed
- Jun 15, 2022
- Trade date
- Jun 13-14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $160.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Byam RebeccaCIK 0001866256 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2022 | Common Stock | PPurchaseAcquired | +7,596 | $2.08 | +$15,799.68 | 96,596 | Direct | |
| Jun 14, 2022 | Common Stock | PPurchaseAcquired | +58,856 | $2.46 | +$144,785.76 | 155,452 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.